x
Breaking News
0

Suven Life Sciences Ltd (SUVP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
188.40 +2.90    +1.56%
09:58:37 - Real-time Data. Currency in INR ( Disclaimer )
Type: Equity
Market: India
ISIN: INE495B01038 
S/N: SUVEN
  • Volume: 79,224
  • Bid/Ask: 188.40 / 188.50
  • Day's Range: 186.25 - 189.15
Start Trading
Suven Life Sciences Ltd 188.40 +2.90 +1.56%

SUVP Overview

 
Information about the Suven Life Sciences Ltd Share. You can find more details by going to one of the sections listed on this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close185.5
Day's Range186.25 - 189.15
Revenue5B
Open186.25
52 wk Range155 - 230.4
EPS5.65
Volume79,224
Market Cap23.61B
Dividend (Yield)1 (0.54%)
Average Volume (3m)572,844
P/E Ratio32.86
Beta1.04
1-Year Change4.42%
Shares Outstanding127,282,478
Next Earnings DateN/A
What is your sentiment on Suven Life Sciences Ltd?
or
Vote to see community's results!

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Buy Buy Neutral Sell Buy
Technical Indicators Strong Buy Strong Buy BUY Strong Sell Sell
Summary Strong Buy Strong Buy Neutral Strong Sell Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Completed Patterns
Three Outside Up 1M 2 Oct 17
Bullish Engulfing 1M 3 Sep 17
Morning Doji Star 1W 3 Nov 19, 2017
Bullish doji Star 1W 4 Nov 12, 2017
Homing Pigeon 5H 5 Dec 12, 2017 07:30

Suven Life Sciences Ltd News & Analysis

Suven Life Sciences Ltd Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NSE 188.40 188.40 188.50 79,224 +1.56% INR 09:58:37  
  BSE 187.85 187.55 187.80 2,353 +1.21% INR 09:43:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Tech Mahindra 514.00 518.15 503.00 +10.40 +2.07% 1.25M 09:59:00  
  Tata Communications 721.00 754.00 711.25 +24.60 +3.53% 3.38M 09:58:57  
  Vedanta 284.80 288.05 283.85 +1.25 +0.44% 1.82M 09:59:03  
  Federal Bank 104.95 105.95 104.65 -0.05 -0.05% 998.00K 09:58:43  
  Tata Consultancy 2,587.40 2,632.00 2,578.10 -41.00 -1.56% 425.34K 09:58:43  
  Oil & Natural Gas 184.80 186.70 184.25 +0.90 +0.49% 1.18M 09:58:46  
  Bharti Infratel 361.90 362.90 358.20 +4.20 +1.17% 456.10K  
  Bharat Petroleum 510.40 513.00 508.00 +4.10 +0.81% 542.09K 09:58:33  
  GAIL Ltd 487.20 497.10 484.70 -4.60 -0.94% 701.66K 09:58:44  
  AVT Natural Products Ltd 55.85 57.30 54.80 +1.50 +2.76% 878.60K 09:58:44  

Suven Life Sciences Ltd Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

954

Equity Type

ORD

Suven Life Sciences Limited is a bio-pharmaceutical company. The Company is engaged in the business of manufacture and sale of bulk drugs and intermediaries. The Company's segments include Manufacturing (CRAMS), which develops and produces bulk drugs and intermediates under contract manufacturing services; Services (DDDSS), which consists of collaborative research projects (CRP), clinical trials, and testing and analysis services, and Research and Development. Its products consist of active pharmaceutical ingredients (APIs), including Aripiprazole, Armodafinil, Calcium Acetate, Carprofen, Deferasirox, Doxofylline, Entacapone, Fenoprofen Calcium, Rosuvastatin Calcium, Sitagliptin Phosphate and Solifenacin succinate, and intermediates, including 2-nitro phenyl acetic acid and 3,4-dichlorobenzylamine. The Company is engaged in the drug discovery specializing in central nervous system (CNS)-based programs with over four of the molecules in pipeline under clinical phase of development.

Read More

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Suven Life Sciences Ltd
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email